A Phase 2 Study in Patients With Moderate-to-Severe Psoriasis

Mise à jour : Il y a 5 ans
Référence : EUCTR2010-018948-14

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of this study is to test the hypothesis that at least 1 LY2439821 treatment group is superior to placebo in the proportion of adult patients with moderate-to-severe chronic plaque psoriasis who achieve a 75% improvement from baseline to Week 12 in the Psoriasis Area and Severity Index (PASI 75) and to estimate the percentage PASI improvement by treatment using regression techniques.


Critère d'inclusion

  • Patients With Moderate-To-Severe Psoriasis

Liens